BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7797915)

  • 1. Establishment of novel lymphoid cell lines dually infected with human T cell lymphotropic viruses types I and II.
    Kubota T; Morishita N; Tanaka Y; Sawada T; Miyagi T; Ohtsuki Y; Miyoshi I
    J Infect Dis; 1995 Jul; 172(1):220-4. PubMed ID: 7797915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual infection of rabbits with human T cell lymphotropic virus types I and II.
    Machida H; Morishita N; Ikezoe T; Sawada T; Ohtsuki Y; Miyoshi I
    Jpn J Cancer Res; 1997 Feb; 88(2):137-42. PubMed ID: 9119741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
    Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
    J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens.
    Vallejo A; García-Sáiz A
    J Virol Methods; 1995 Jan; 51(1):9-17. PubMed ID: 7730441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of guinea pig leukocytes by coinfection with human T-cell lymphotropic virus types I and II.
    Murakami K; Hatakeyama N; Ikezoe T; Kubota T; Kubonishi I; Ohtsuki Y; Sawada T; Miyoshi I
    J Hum Virol; 1998; 1(2):101-6. PubMed ID: 10195239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, characterization, and transmission of human T-lymphotropic virus types I and II in culture.
    Kitamura K; Rudolph DL; Goldsmith C; Folks TM; Lal RB
    Curr Microbiol; 1993 Dec; 27(6):355-60. PubMed ID: 7764258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human immunodeficiency virus (HIV) and human lymphotropic virus (HTLV) type I or II dual infections by polymerase chain reaction.
    De BK; Srinivasan A
    Oncogene; 1989 Dec; 4(12):1533-5. PubMed ID: 2594369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
    Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
    J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA; Eirin ME; Pando MA; Biglione MM
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
    Heneine W; Khabbaz RF; Lal RB; Kaplan JE
    J Clin Microbiol; 1992 Jun; 30(6):1605-7. PubMed ID: 1624585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Southernmost carriers of HTLV-I/II in the world.
    Cartier L; Araya F; Castillo JL; Zaninovic V; Hayami M; Miura T; Imai J; Sonoda S; Shiraki H; Miyamoto K
    Jpn J Cancer Res; 1993 Jan; 84(1):1-3. PubMed ID: 8449820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.
    Lal RB; Rudolph DL; Griffis KP; Kitamura K; Honda M; Coligan JE; Folks TM
    J Virol; 1991 Apr; 65(4):1870-6. PubMed ID: 2002547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
    Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
    J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II.
    Prince HE; York J; Owen SM; Lal RB
    Clin Exp Immunol; 1995 Nov; 102(2):256-61. PubMed ID: 7586675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction.
    De Rossi A; Mammano F; Del Mistro A; Chieco-Bianchi L
    Eur J Cancer; 1991; 27(7):835-8. PubMed ID: 1834112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reexamination of human T cell lymphotropic virus (HTLV-I/II) prevalence.
    Zucker-Franklin D; Pancake BA; Marmor M; Legler PM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6403-7. PubMed ID: 9177230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.